![Josie Yang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Josie Yang
Keine laufenden Positionen mehr
Profil
Josie Yang worked as Vice President & Head-Global Regulatory Strategy at PTC Therapeutics, Inc., Vice President & Head-Regulatory Affairs at Avrobio, Inc., and Associate Vice President-Global Regulatory Affairs at ImClone Systems Corp.
Dr. Yang holds a doctorate degree from Auburn University and National Taiwan University.
Ehemalige bekannte Positionen von Josie Yang
Unternehmen | Position | Ende |
---|---|---|
PTC THERAPEUTICS, INC. | Corporate Officer/Principal | - |
ImClone Systems Corp. | General Counsel | - |
TECC THERPAR | Public Communications Contact | - |
Ausbildung von Josie Yang
Auburn University | Doctorate Degree |
National Taiwan University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PTC THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Avrobio, Inc.
![]() Avrobio, Inc. BiotechnologyHealth Technology AVROBIO, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. The firm's clinical-stage programs include Fabry, Gaucher Type 1, Hunter syndrome Gaucher Type 3, Pompe, and Cystinosis. The company was founded by Geoff Mackay, Kim Warren, Christopher Mason, and Jeffrey Medin in 2015 and is headquartered in Watertown, MA. | Health Technology |
ImClone Systems Corp. | Health Technology |